Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hermes

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
ACS Chemical Biology|October 7, 2011
Parsimonious discovery of synergistic drug combinationsBryan Severyn, Robert A Liehr, Alex Wolicki, et al.
Molecular Endocrinology (Baltimore, Md.)|October 17, 1998
Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transferG Zhou, R Cummings, Y Li, et al.
Journal of Biomolecular Screening|February 15, 2015
Screening of HIV-1 Protease Using a Combination of an Ultra-High-Throughput Fluorescent-Based Assay and RapidFire Mass SpectrometryJuncai Meng, Ming-Tain Lai, Vandna Munshi, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2011
Thiophenyl oxime-derived phosphonates as nano-molar class C beta-lactamase inhibitors reducing MIC of imipenem against Pseudomonas aeruginosa and Acinetobacter baumanniiQiang Tan, Aimie M Ogawa, Susan L Raghoobar, et al.
Biochemistry|July 2, 1991
Human fibroblast stromelysin catalytic domain: expression, purification, and characterization of a C-terminally truncated formA I Marcy, L L Eiberger, R Harrison, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1993
Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cellsH J Zweerink, M C Gammon, U Utz, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Tetrapeptide derived inhibitors of complexation of a class II MHC: the peptide backbone is not inviolateA B Jones, J J Acton, M N Rivetna, et al.
Human Immunology|August 1, 1993
Recognition by HLA-A2-restricted cytotoxic T lymphocytes of endogenously generated and exogenously provided synthetic peptide analogues of the influenza A virus matrix proteinS Y Sauma, M C Gammon, M A Bednarek, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2002
A peptide-based fluorescence resonance energy transfer assay for Bacillus anthracis lethal factor proteaseRichard T Cummings, Scott P Salowe, Barry R Cunningham, et al.
Nature Structural Biology|February 1, 1994
The NMR structure of the inhibited catalytic domain of human stromelysin-1P R Gooley, J F O'Connell, A I Marcy, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
ACS Chemical Biology|October 7, 2011
Parsimonious discovery of synergistic drug combinationsBryan Severyn, Robert A Liehr, Alex Wolicki, et al.
Molecular Endocrinology (Baltimore, Md.)|October 17, 1998
Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transferG Zhou, R Cummings, Y Li, et al.
Journal of Biomolecular Screening|February 15, 2015
Screening of HIV-1 Protease Using a Combination of an Ultra-High-Throughput Fluorescent-Based Assay and RapidFire Mass SpectrometryJuncai Meng, Ming-Tain Lai, Vandna Munshi, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2011
Thiophenyl oxime-derived phosphonates as nano-molar class C beta-lactamase inhibitors reducing MIC of imipenem against Pseudomonas aeruginosa and Acinetobacter baumanniiQiang Tan, Aimie M Ogawa, Susan L Raghoobar, et al.
Biochemistry|July 2, 1991
Human fibroblast stromelysin catalytic domain: expression, purification, and characterization of a C-terminally truncated formA I Marcy, L L Eiberger, R Harrison, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1993
Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cellsH J Zweerink, M C Gammon, U Utz, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Tetrapeptide derived inhibitors of complexation of a class II MHC: the peptide backbone is not inviolateA B Jones, J J Acton, M N Rivetna, et al.
Human Immunology|August 1, 1993
Recognition by HLA-A2-restricted cytotoxic T lymphocytes of endogenously generated and exogenously provided synthetic peptide analogues of the influenza A virus matrix proteinS Y Sauma, M C Gammon, M A Bednarek, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2002
A peptide-based fluorescence resonance energy transfer assay for Bacillus anthracis lethal factor proteaseRichard T Cummings, Scott P Salowe, Barry R Cunningham, et al.
Nature Structural Biology|February 1, 1994
The NMR structure of the inhibited catalytic domain of human stromelysin-1P R Gooley, J F O'Connell, A I Marcy, et al.
Pageof 8